The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Bacterial Vaginosis: Developing Drugs for Treatment.'' The purpose of this guidance is to assist sponsors in the clinical development of drugs for the treatment of bacterial vaginosis (BV).
Document
Bacterial Vaginosis: Developing Drugs for Treatment; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Bacterial Vaginosis: Developing Drugs for Treatment.'...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
81 FR 45509
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Bacterial Vaginosis: Developing Drugs for Treatment; Draft Guidance for Industry; Availability,” thefederalregister.org (July 14, 2016), https://thefederalregister.org/documents/2016-16636/bacterial-vaginosis-developing-drugs-for-treatment-draft-guidance-for-industry-availability.